Cariou, B., Hanf, R., Lambert-Porcheron, S., Zaïr, Y., Sauvinet, V., Noël, B., . . . Laville, M. (2013). Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects. American Diabetes Association.
Citação norma ChicagoCariou, Bertrand, et al. Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects. American Diabetes Association, 2013.
Citação norma MLACariou, Bertrand, et al. Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects. American Diabetes Association, 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.